Revenue by Segment

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2014
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '14 Dec 31, 2014
Drug Discovery Support Business	593.29M	577.86M	682.46M	630.82M	609.92M
Drug Discovery Support Business Growth	2.67%	-15.33%	8.19%	3.43%	27.69%
Drug Discovery and Development Business	-	202.95M	-	-	103.01M
Drug Discovery and Development Business Growth	-	-	-	-	3112.13%
Total	593.29M	780.81M	682.46M	630.82M	712.93M
Total Growth	-24.02%	14.41%	8.19%	-11.52%	48.26%

Source: S&P Global Market Intelligence.